Clinical Trial Update: DHA and Vitamin D in Children With Biopsy-proven NAFLD [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating DHA and vitamin D in children with biopsy-confirmed non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Non-alcoholic Steatohepatitis

Drugs mentioned

• DHA (Docosahexaenoic acid)
• Vitamin D (Cholecalciferol)

Snippet

Sponsor: Bambino Gesù Hospital and Research Institute | Conditions: NAFLD, Non Alcoholic Steatohepatitis (NASH) | Phase 3 | Status: COMPLETED